30 Buxton Farm Road, Ste. 230 Stamford, CT 06905 (203) 914-1903 info@neinh.com

Migraine Headaches

Migraine is a chronic medical condition affecting an estimated 38 million people in the United States.  Throbbing, often one-sided moderate-to-severe head pain, accompanied by light and sound sensitivity and nausea/vomiting are the most common symptoms.  Some migraine sufferers experience dizziness, visual symptoms, numbness or weakness on one side of the body, slowed thinking or trouble speaking.

Migraine predominantly effects young and middle-aged woman (that is, during their prime work and child-rearing years), though it can strike men and children as well. When untreated, the World Health Organization lists migraine as among the top ten most disabling medical conditions.

Our migraine research program aims to find better acute and preventive treatments for adults and children who suffer from migraine. Our current and upcoming studies include:

  • We are currently conducting a trial looking into the preventative treatment of migraine in people with Major Depressive Disorder. This study begins with a three-month, double blind period. The study medication is an injection that will last for about one month. After this first phase of the study, is an open label period where you will receive the study medication for another three months. Click the button to view more information about this study on clinicaltrials.gov.   Learn More
  • This study is looking at a new medication for Migraine headaches for those who just can’t seem to find relief. This medication is functionally different from the current medications, so it is perfect for those patients who have not found relief from the currently available medications and are still looking. This is being testing as a preventative medication administered through IV infusion. The study will involve coming to our clinic for about twice a month for a total length of 5 months. Click the button to view more information about this study on clinicaltrials.gov. Learn More
  • NEICR is enrolling for another nasal spray medication study. This study is a single dose study, meaning that any person qualified to enroll in the study will receive a single dose of either placebo or active medication to treat a single migraine. This study is looking for patients who have a minimum of two and maximum of eight migraines in a single month. The total time investment for this trial is three office visits over a period of two and a half months. Click the button to view information about this study on clinicaltrials.gov.  Learn More
  • Another trial we have for those who don’t like pills or shots, is a trial that is testing a device for medication delivery. In this trial, the device uses a small catheter placed deep in the nose to instill a tiny spray of medicine onto the SPG, a pain nerve that sits between the nose and brain.  This study is for those with Chronic Migraine (15 or more headache days per month). Click the button to view information about this study on clinicaltrials.gov.    Learn More

All studies at NEICR are available at no cost to you, and there may be compensation for time and travel.  Participation is completely voluntary, and you may withdraw at any time. To find out more about any of our studies, give us a call at 203-914-1903 or fill out the form below.

Use the form below to let us know you are interested:

Adult Migraine - Clinical Study Enrollment